Barclays’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-115,900
| Closed | -$9.49M | – | 5434 |
|
|
2024
Q4 | $9.49M | Buy |
115,900
+51,200
| +79% | +$4.26M | ﹤0.01% | 1614 |
|
|
2024
Q3 | $5.34M | Buy |
+64,700
| New | +$4.83M | ﹤0.01% | 2041 |
|
|
2024
Q2 | – | Sell |
-271,000
| Closed | -$20.1M | – | 5143 |
|
|
2024
Q1 | $20.1M | Buy |
271,000
+141,700
| +110% | +$9.88M | 0.01% | 983 |
|
|
2023
Q4 | $8.55M | Buy |
+129,300
| New | +$8.09M | ﹤0.01% | 1630 |
|
|
2023
Q2 | – | Sell |
-705,400
| Closed | -$40.9M | – | 4875 |
|
|
2023
Q1 | $40.9M | Buy |
705,400
+434,800
| +161% | +$29.3M | 0.02% | 545 |
|
|
2022
Q4 | $19.6M | Buy |
+270,600
| New | +$19.4M | 0.01% | 903 |
|
|
2022
Q3 | – | Sell |
-272,000
| Closed | -$17.1M | – | 5004 |
|
|
2022
Q2 | $17.1M | Sell |
272,000
-480,200
| -64% | -$31.8M | 0.01% | 782 |
|
|
2022
Q1 | $52.9M | Buy |
752,200
+585,200
| +350% | +$39.6M | 0.04% | 396 |
|
|
2021
Q4 | $10.4M | Buy |
+167,000
| New | +$10.5M | ﹤0.01% | 1249 |
|
|
2021
Q2 | – | Sell |
-200,000
| Closed | -$12.2M | – | 4999 |
|
|
2021
Q1 | $12.2M | Buy |
200,000
+104,600
| +110% | +$5.77M | 0.01% | 1004 |
|
|
2020
Q4 | $4.48M | Hold |
95,400
| – | – | ﹤0.01% | 1587 |
|
|
2020
Q3 | $3.55M | Sell |
95,400
-70,100
| -42% | -$2.66M | ﹤0.01% | 1642 |
|
|
2020
Q2 | $6.04M | Sell |
165,500
-197,800
| -54% | -$6.89M | ﹤0.01% | 1232 |
|
|
2020
Q1 | $11.1M | Buy |
363,300
+73,900
| +26% | +$3.28M | 0.01% | 932 |
|
|
2019
Q4 | $14.8M | Buy |
289,400
+234,500
| +427% | +$11.3M | 0.01% | 1133 |
|
|
2019
Q3 | $2.59M | Buy |
54,900
+7,300
| +15% | +$348K | ﹤0.01% | 2545 |
|
|
2019
Q2 | $2.36M | Sell |
47,600
-13,600
| -22% | -$639K | ﹤0.01% | 2703 |
|
|
2019
Q1 | $2.6M | Sell |
61,200
-85,800
| -58% | -$3.79M | ﹤0.01% | 2298 |
|
|
2018
Q4 | $6.04M | Sell |
147,000
-60,300
| -29% | -$2.59M | ﹤0.01% | 1474 |
|
|
2018
Q3 | $9.69M | Buy |
207,300
+24,000
| +13% | +$1.1M | 0.01% | 1283 |
|
|
2018
Q2 | $7.99M | Sell |
183,300
-355,900
| -66% | -$16.6M | 0.01% | 1387 |
|
|
2018
Q1 | $24.7M | Buy |
539,200
+218,700
| +68% | +$10.6M | 0.02% | 743 |
|
|
2017
Q4 | $16.2M | Sell |
320,500
-1,500
| -0.5% | -$79K | 0.01% | 922 |
|
|
2017
Q3 | $16.7M | Sell |
322,000
-116,478
| -27% | -$5.67M | 0.02% | 742 |
|
|
2017
Q2 | $21.5M | Buy |
438,478
+237,303
| +118% | +$11M | 0.02% | 572 |
|
|
2017
Q1 | $9.47M | Buy |
201,175
+4,713
| +2% | +$225K | 0.01% | 909 |
|
|
2016
Q4 | $9.44M | Buy |
196,462
+29,172
| +17% | +$1.34M | 0.01% | 972 |
|
|
2016
Q3 | $6.63M | Sell |
167,290
-73,491
| -31% | -$2.76M | 0.01% | 1098 |
|
|
2016
Q2 | $8.55M | Buy |
240,781
+130,601
| +119% | +$5.09M | 0.01% | 927 |
|
|
2016
Q1 | $4.22M | Sell |
110,180
-78,765
| -42% | -$2.94M | 0.01% | 1314 |
|
|
2015
Q4 | $8.08M | Buy |
188,945
+13,576
| +8% | +$597K | 0.01% | 1005 |
|
|
2015
Q3 | $7.35M | Buy |
175,369
+80,560
| +85% | +$3.76M | 0.01% | 1119 |
|
|
2015
Q2 | $4.65M | Sell |
94,809
-74,613
| -44% | -$3.53M | 0.01% | 1539 |
|
|
2015
Q1 | $7.55M | Sell |
169,422
-1,008,566
| -86% | -$45.3M | 0.01% | 1262 |
|
|
2014
Q4 | $56.7M | Buy |
1,177,988
+618,671
| +111% | +$29.4M | 0.05% | 309 |
|
|
2014
Q3 | $26.4M | Buy |
559,317
+79,101
| +16% | +$3.84M | 0.03% | 581 |
|
|
2014
Q2 | $23.5M | Sell |
480,216
-15,484
| -3% | -$725K | 0.02% | 625 |
|
|
2014
Q1 | $23M | Buy |
495,700
+75,287
| +18% | +$3.46M | 0.03% | 610 |
|
|
2013
Q4 | $19.9M | Buy |
420,413
+133,181
| +46% | +$5.97M | 0.02% | 768 |
|
|
2013
Q3 | $11.8M | Sell |
287,232
-249,645
| -46% | -$10.8M | 0.01% | 1024 |
|
|
2013
Q2 | $21.9M | Buy |
+536,877
| New | +$19.7M | 0.03% | 604 |
|
Other funds holding MET
VCM
VPM
Barclays's MET Position: Q1 2026 in Review
Barclays increased its MetLife (MET) stake by 22% in Q1 2026, buying an estimated $22M and bringing the position to 1,643,804 shares worth $116M. The position accounts for 0.03% of the portfolio, ranked #447.
Barclays first reported a position in MET in Q2 2013 and has held it in 52 quarters since. The position peaked at $673M in Q4 2021. 1,372 funds tracked by Wall St. Rank hold MET as of Q1 2026.
- Barclays held 1,643,804 shares of MetLife worth $116M as of Q1 2026.
- Barclays bought 293,668 MetLife shares in Q1 2026, an estimated $22M.
- MetLife made up 0.03% of Barclays's portfolio in Q1 2026, its #447 holding.
- Barclays first reported a position in MetLife in Q2 2013 and has held it in 52 quarters since.
- Barclays's MetLife position peaked at $673M in Q4 2021.
- 1,372 funds tracked by Wall St. Rank held MetLife as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.